Finasteride Cost in Montana (2026): Cash Prices, Insurance, Medicaid & Savings

What Generic Finasteride Actually Costs at Montana Pharmacies

The average cash price for a 30-day supply of generic finasteride 1 mg across Montana retail pharmacies sits at roughly $12 in 2026. That number varies by city. Billings and Missoula pharmacies tend to cluster between $8 and $14, while rural pharmacies in towns like Miles City or Glasgow may charge $15 to $20 due to lower prescription volume and higher overhead.

Brand-name Propecia (Merck) carries a manufacturer list price near $85 per month, but fewer than 5% of finasteride prescriptions in the U.S. are filled as brand-name at this point. The FDA-approved labeling for finasteride confirms bioequivalence between generic and brand formulations, meaning the clinical effect is identical. Pharmacy discount programs from GoodRx, RxSaver, and Amazon Pharmacy can push Montana generic prices as low as $4 for a 30-day supply at participating chains like Walmart, Costco, and Albertsons.

A pricing comparison across Montana locations:

| Pharmacy type | Approximate monthly cost (1 mg generic) | |---|---| | Big-box (Walmart, Costco) | $4 to $8 | | Chain (Walgreens, Albertsons) | $10 to $14 | | Independent rural pharmacy | $12 to $20 | | Mail-order (Mark Cuban Cost Plus, etc.) | $5 to $9 |

Mail-order pharmacies ship to all Montana ZIP codes and often beat local retail pricing by 30% to 50%.

Montana Medicaid and Finasteride: What's Covered

Montana Medicaid does not cover finasteride when prescribed for male pattern hair loss (androgenetic alopecia). Hair loss is classified as a cosmetic indication under Montana's Medicaid formulary, which excludes drugs prescribed solely for cosmetic purposes.

For benign prostatic hyperplasia (BPH), the picture changes. Montana Medicaid does include finasteride 5 mg on its preferred drug list for BPH when prescribed with a documented diagnosis. Prior authorization is typically not required for the BPH indication, though the prescribing clinician must confirm the ICD-10 code (N40.1 or related) on the prescription.

The American Urological Association 2023 BPH guidelines recommend 5-alpha reductase inhibitors including finasteride for men with prostate volumes exceeding 30 mL. Montana Medicaid aligns with this recommendation.

If you are a Montana Medicaid enrollee seeking finasteride for hair loss, the out-of-pocket cost at $12 per month for generic makes it one of the more affordable self-pay prescriptions available. Some Montana community health centers also maintain discount formularies that include finasteride at reduced rates for low-income patients regardless of Medicaid status.

Insurance Coverage for Finasteride in Montana

Most commercial health plans sold on the Montana exchange (Blue Cross Blue Shield of Montana, PacificSource, and Montana Health CO-OP) cover generic finasteride for BPH. Coverage for the 1 mg hair-loss indication is less consistent.

Blue Cross Blue Shield of Montana classifies finasteride 1 mg for androgenetic alopecia as a Tier 2 generic on some plans but excludes it entirely on others. The determining factor is usually whether the plan includes a cosmetic exclusion clause. PacificSource plans in Montana generally exclude hair-loss medications from formulary coverage.

For plans that do cover finasteride for hair loss, copays typically range from $5 to $15 for a 30-day supply. That range is close enough to the uninsured cash price that using a discount card instead of insurance sometimes saves money, particularly if your deductible has not been met.

A practical approach: ask your pharmacist to run the prescription through both your insurance and a discount card, then choose whichever option produces the lower price at the register. Montana law does not prohibit pharmacists from informing you of the lower-cost option. This matters because studies show medication adherence drops significantly when out-of-pocket costs exceed perceived value, and finasteride requires continuous daily use to maintain its clinical effect.

Compounded Finasteride in Montana: Legality and Cost

Compounded finasteride is legal in Montana through licensed 503A compounding pharmacies. These pharmacies operate under individual patient prescriptions and are regulated by the Montana Board of Pharmacy.

The typical cost for compounded finasteride in Montana is approximately $45 per month. That price is higher than generic tablets because compounding labor, specialized ingredients, and quality testing add cost. Compounded formulations make clinical sense in specific situations: patients who need a non-standard dose, those who require topical finasteride to reduce systemic exposure, or individuals who need finasteride combined with minoxidil in a single topical preparation.

Montana does not have 503B outsourcing facilities within state borders as of 2026, but 503B-compounded finasteride products from out-of-state facilities (registered with the FDA under Section 503B) can legally ship to Montana patients with a valid prescription. The distinction matters: 503A pharmacies compound per individual prescription, while 503B facilities can produce larger batches under cGMP-like conditions.

Topical finasteride, which has gained attention for potentially lowering systemic DHT suppression compared to oral dosing, is only available through compounding in the U.S. A 2022 meta-analysis published in the Journal of the American Academy of Dermatology found that topical finasteride 0.25% applied once daily produced hair count improvements comparable to oral finasteride 1 mg while resulting in lower serum DHT reduction (34% vs. 55% to 70%). For patients concerned about sexual side effects, this route may be worth discussing with a prescriber.

Clinical Background: Why Finasteride Works and What the Evidence Shows

Finasteride inhibits Type II 5-alpha reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). In the scalp, DHT miniaturizes hair follicles in genetically susceptible individuals. Blocking its production slows or reverses that process.

The foundational evidence comes from the Kaufman et al. trial published in the Journal of the American Academy of Dermatology in 1998. That study followed 1,553 men aged 18 to 41 with mild-to-moderate vertex hair loss over two years. At 24 months, finasteride 1 mg daily produced a mean increase of 138 hairs in a 1-inch diameter target area, compared to a loss of 38 hairs in the placebo group. Investigator assessments rated 66% of finasteride-treated men as improved versus 7% of placebo-treated men.

Long-term extension data from the same cohort showed sustained benefit at five years. Men who continued finasteride maintained their hair count gains, while those switched to placebo lost the regrowth within 12 months. This finding underscores a cost-relevant point: finasteride is a maintenance medication, not a cure. Stopping treatment reverses its effects.

For BPH, the Proscar Long-Term Efficacy and Safety Study (PLESS, N=3,040) demonstrated that finasteride 5 mg reduced prostate volume by a median of 18% over four years and decreased the risk of acute urinary retention by 57% compared to placebo (McConnell et al., NEJM 1998). These outcomes led the AUA and the Endocrine Society to include finasteride in first-line BPH management guidelines.

Side Effects and the Cost of Managing Them

Sexual side effects occur in a minority of finasteride users but receive outsized attention. In the Kaufman trial, 3.8% of finasteride-treated men reported decreased libido compared to 2.1% on placebo. Erectile dysfunction occurred in 1.3% versus 0.7%. These differences, while statistically present, are small in absolute terms.

The concept of "post-finasteride syndrome" (persistent sexual dysfunction after stopping the drug) remains scientifically contested. The NIH-funded Post-Finasteride Syndrome Foundation studies have reported cases, but no controlled trial has established a causal mechanism distinct from nocebo effect. The FDA updated the finasteride label in 2012 to note reports of sexual side effects persisting after discontinuation, but the label does not confirm causation.

From a cost perspective, side effect concerns can lead to treatment discontinuation, which wastes the investment in prior months of therapy and reverses hair regrowth. The practical recommendation from the American Hair Loss Association is to commit to at least a 12-month trial before evaluating efficacy, and to discuss any side effects with a prescriber rather than stopping abruptly.

Telehealth Access to Finasteride in Montana

Montana permits telehealth prescribing of finasteride. The state's telehealth parity law (Montana Code 33-22-138) requires insurers to cover telehealth visits at the same rate as in-person visits, which means an initial consultation for finasteride via telehealth should carry the same copay as an office visit.

Several national telehealth platforms prescribe finasteride to Montana residents: Hims, Keeps, Ro, and HealthRX all operate in Montana. Pricing models vary. Some platforms bundle the consultation fee into the medication cost (typically $20 to $30 per month all-in). Others charge a consultation fee ($25 to $75) separately from the prescription, which can then be filled at any Montana pharmacy at the cash or insured price.

For residents of rural Montana, where the nearest dermatologist or urologist may be over 100 miles away, telehealth removes a meaningful barrier. A 2021 study in JAMA Dermatology found that teledermatology consultations for hair loss produced treatment plans concordant with in-person evaluations 85% of the time.

The most cost-effective approach for many Montana patients: obtain a finasteride prescription via telehealth ($0 to $25 for the visit if insured), then fill the generic at a big-box pharmacy using a discount card ($4 to $8 per month). Total monthly cost: under $10 in many cases.

How to Find the Lowest Finasteride Price in Montana

Step one is always to fill generic, not brand. The clinical outcomes are identical.

Step two: compare prices before filling. Use GoodRx, RxSaver, or the pharmacy's own app. Prices fluctuate weekly, and the cheapest pharmacy this month may not be cheapest next month. Costco pharmacies in Montana (Billings, Missoula) do not require a membership to use the pharmacy and consistently rank among the lowest-cost options.

Step three: consider 90-day fills. Many pharmacies offer a lower per-unit cost on 90-day supplies. A 90-day generic finasteride supply at Costco may run $9 to $12 total, a per-month equivalent of $3 to $4.

Step four: check manufacturer and pharmacy discount programs. Merck's savings card applies to brand Propecia and is irrelevant for patients using generics, which is most people. However, chains like Walmart have $4 generic programs that include finasteride.

Step five: for patients with BPH who also want hair-loss benefit, one approach some clinicians use is prescribing finasteride 5 mg (the BPH dose, which is more likely to be covered by insurance) and having the patient quarter the tablet. A pill cutter costs $3. This is off-label for the hair-loss indication, but the pharmacokinetic data shows that 1.25 mg (one quarter of 5 mg) suppresses DHT to a similar degree as 1 mg. Some prescribers are comfortable with this approach; discuss it with yours.

Montana-Specific Discount and Assistance Programs

Montana does not operate a state-level prescription assistance program specific to finasteride. However, several resources apply:

The Montana DPHHS Healthy Montana Kids Plus (HMK Plus) program covers medically necessary prescriptions for children and young adults, though finasteride is rarely prescribed in this population.

The Big Sky Rx program, Montana's state pharmaceutical assistance program for Medicare beneficiaries, helps eligible seniors with drug costs. Finasteride for BPH could fall under this program for qualifying individuals aged 65 and older.

For uninsured or underinsured adults, NeedyMeds and RxAssist maintain databases of patient assistance programs. Generic finasteride is inexpensive enough that it falls below the threshold of most manufacturer assistance programs (which target high-cost specialty drugs), but pharmacy-level discount cards remain effective.

Community health centers funded under Section 330 of the Public Health Service Act, including several in Montana (Bullhook Community Health Center in Havre, RiverStone Health in Billings), can access 340B drug pricing. Patients seen at these centers may obtain finasteride at significantly reduced cost through the 340B program, sometimes as low as $1 to $3 per month.